Cannabix Technologies Inc. (CSE: BLO) (OTCID: BLOZF) (Frankfurt: 8CT) (the “Company” or “Cannabix”) and Omega Laboratories, Inc. (“Omega”) announce the development and validation of a DOT-like ...
Omega Laboratories, Inc. ("Omega"), and Cannabix Technologies Inc. ("Cannabix") (CSE: BLO) (OTCID: BLOZF) announce the development and validation of ...
Background Rheumatic heart disease (RHD) remains a major cause of morbidity and mortality in low-resource settings, ...
AI made experiments cheap to run, not easy to trust. Build an experimentation framework that gets harder to pass as the tests ...
The rise of automation and AI has raised fears about job loss, but smart tools can also train workers rather than replace ...
Background Adult-onset Still’s disease (AOSD) is a systemic autoinflammatory disorder lacking a gold-standard diagnostic ...
The AI revolution is significantly outpacing the IC industry’s ability to sufficiently test multi-chip systems for all necessary failure mechanisms at probe, final test, and system-level test. The ...
First shown as a proof of concept six years ago, the Czinger 21C still stands out as a spectacle of advanced design and ...
The BEA is revising PCE inflation methodology, with analysts expecting a 0.2 percentage point reduction in core readings when ...
AI benchmark cheating has been theorized as an inevitable consequence of training capable optimizers against fixed metrics. With OpenAI's GPT-5.6 Sol, the theory arrived in full view. The nonprofit ...
A U.S. company has launched the first system to test hypersonic vehicle materials against real weather before flight at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results